Naramig, Filmtabletten

7680542720142 CH-54272 Filmtabletten
Naramig, Filmtabletten
Naramig, Filmtabletten
Naramig, Filmtabletten
1 / 3
google

Article details

Package size
6
Selling units
6
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
94.07 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 39.70
Specialties list
Yes
Generic
No
SL addition date: 15/03/1998

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54272
Drug name
Naramig, Filmtabletten
Galenic form
TAB
ATC Code
N02CC02
Authorization status
Z
Dispensing category
B
First authorization
30/09/1997
Authorization expiration date
31/12/9999
IT Number
02.05.1.
Domain
Human medicine
Field of application
Akutbehandlung von Migräneanfällen mit oder ohne Aura

Package details

Description (FR)
NARAMIG cpr pell 2.5 mg 6 pce
Description (DE)
NARAMIG Filmtabl 2.5 mg 6 Stk
Market launch
30/09/1997
Narcotic (BTM)
No

Other package sizes (1)

NARAMIG cpr pell 2.5 mg 12 pce
12 TABL
GTIN: 7680542720227
View